Rare diseases
Investigational molecules
Locations
Back to France1 478 clinical trials in Marseille, France across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Vericiguat for Children with Heart Failure from Left Ventricular Systolic Dysfunction
FranceLong-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension
FranceStudy of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer
FranceStudy on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma
FranceStudy of adagrasib in elderly patients (70 years or older) or patients with poor performance status who have KRAS G12C mutation-positive non-small cell lung cancer
FranceStudy on the Effects of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) in Patients with Progressive Supranuclear Palsy
FranceStudy on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy
FranceStudy on Skin Care for Patients with Advanced EGFR-Mutated Lung Cancer Treated with Amivantamab and Lazertinib
FranceStudy on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy
FranceStudy of Relatlimab, Nivolumab, and Drug Combination for Patients with Advanced Cancer
FranceStudy of BMS-986253 with Nivolumab and Ipilimumab for Patients with Advanced Solid Tumors
FranceComparing Methotrexate and Tocilizumab for Treating Giant Cell Arteritis in Patients: A Study on Effectiveness and Safety
FranceThe busiest research cities in the country
What the registry says about research in the country
Studies focusing on innovative treatments for head and neck squamous cell carcinoma, examining novel therapies and combinations with radiotherapy. Research includes investigations into endometrial cancer and bladder cancer treatments.
Particular emphasis on combining immunotherapy with conventional treatments for improved patient outcomes.
Innovative research addressing heart failure prevention and treatment of acute myocardial infarction. Studies include new approaches for managing hypertriglyceridemia and chronic kidney disease.
Focus on developing novel therapeutic approaches and improving patient outcomes in cardiovascular health.
Clinical investigations into multiple sclerosis treatment strategies and management of essential tremor. Research includes innovative approaches for Dravet Syndrome and neurological disorders.
Emphasis on developing targeted therapies for various neurological conditions affecting both adults and children.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
